IRPresswire

NEWS PROVIDED BY

Pharma Stocks Today

August 27, 2025

Zimmer Biomet Logo

WARSAW, Ind., Aug. 27, 2025 — Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that its Board of Directors has approved the payment of a quarterly cash dividend to stockholders for the third quarter of 2025. The cash dividend of $0.24 per share is payable on or about October 31, 2025 to stockholders of record as of the close of business on September 30, 2025.

About Zimmer Biomet

Zimmer Biomet is a global medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health. We seamlessly transform the patient experience through our innovative products and a suite of integrated digital and robotic technologies that leverage data, analytics and artificial intelligence.

With more than 90 years of trusted leadership and proven expertise, Zimmer Biomet delivers high-quality solutions to patients and providers. The company’s culture emphasizes continuous evolution and innovation.

For more information about our product portfolio, operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.com, follow on LinkedIn at www.linkedin.com/company/zimmerbiomet, or on X (Twitter) at www.twitter.com/zimmerbiomet.

Contacts

Media Investors
Kristen Cardillo
925-786-4913
David DeMartino
646-531-6115
Kirsten Fallon
781-779-5561
Zach Weiner
908-591-6955

SOURCE: Zimmer Biomet Holdings, Inc.